SSMO statement on KVV/KLV revision
The SSMO comments on KVV/KLV revision: Statement for the attention of the FOPH Article in the Swiss Medical Journal
About sgmo-adm-bb
This author has not written his bio yet.
But we are proud to say that sgmo-adm-bb contributed 6 entries already.
Entries by sgmo-adm-bb
Swiss Patient Access Program (SPAP)
The SSMO launched the Swiss Patient Access Program (SPAP) in 2023, as a follow-up project to the SPAP pilot. SPAP aims to: Avoid/reduce cases of hardship in processing Art. 71 […]
SSMO · SSOM · SGMO
Swiss Society of Medical Oncology
Società Svizzera di Oncologia Medica
Société Suisse d’Oncologie Médicale
Schweizerische Gesellschaft für Medizinische Onkologie
c/o Pro Medicus GmbH
Minervastrasse 23/25
CH-8032 Zürich
T. +41 (0)43 266 99 12
info@sgmo.ch
